INTRODUCTION
Mupirocin is an effective antibiotic for the elimination of meticillin-resistant Staphylococcus aureus (MRSA) that colonize the nasopharynx. It has been used to control the spread of these micro-organisms among patients during outbreaks (Eltringham, 1997) . Mupirocin-resistant strains are grouped into two distinct categories: low level (Mup RL ), with MICs of 8-256 mg ml
21
, and high level (Mup RH ), with MICs ¢512 mg ml 21 (Eltringham, 1997) . Susceptible strains are defined as those with a MIC ¡4 mg, showing zone diameters of ¢14 mm around 5 mg mupirocin discs (Finlay et al., 1997; Fuchs et al., 1990) . Strains presenting diameters ,14 mm are considered to be mupirocin resistant (either Mup RH or Mup RL ). High-level mupirocin resistance has been associated with failure to clear the organism from patients. However, it has been suggested that Mup RL nasal isolates can still be controlled with mupirocin therapy, as the ointment used contains a much higher mupirocin concentration (20 000 mg ml
) than the Mup RL MICs (Hudson, 1994) . The dilution method is considered the 'gold standard' for the determination of mupirocin-resistance levels. We have recently shown that the mupirocin Etest (AB Biodisk) with tetrazolium reduction is more accurate, thus bringing the Etest closer to the gold standard agar dilution method for determining the mupirocin MICs for S. aureus strains (Mondino et al., 2003) . However, both agar dilution and Etest are too expensive and laborious for routine application. Clinical laboratories are able to differentiate Mup S strains using the 5 mg disc, but the resistant strains can only be distinguished empirically, as Mup RH isolates show heavy growth around the 5 mg mupirocin disc, whereas Mup RL isolates produced hazy zones of inhibition (Deshpande et al., 2002) .
At present, there are no criteria for the disc diffusion method to differentiate between low-and high-level mupirocin resistance. Therefore, we propose the concomitant use of 5 and 200 mg mupirocin discs to distinguish clearly the three susceptibility groups of mupirocinresistant S. aureus strains.
METHODS
Strains and culture conditions. We selected 45 MRSA isolates previously classified by the agar dilution method , as susceptible (13 Mup S ) or low-level (16 Mup RL ) and high-level (16 Mup RH ) mupirocin-resistant strains. The strains were isolated from patients attending the Teaching Hospital of the Federal University of Rio de Janeiro, Brazil. PFGE showed that the isolates belonged to eight different clones or subclones . In addition, susceptible ATCC 25923 and Mup RH HU1A control strains were analysed. PCR analysis revealed that only the Mup RH strains possessed the mupA gene (Nunes et al., 1999) . In the second part of the study, we validated the proposed classification criteria by analysing 79 nosocomial S. aureus strains.
Disc diffusion susceptibility tests. Disc diffusion tests were carried out according to the guidelines of the Clinical and Laboratory Standards Institute (CLSI, 2006) . Plates containing Mueller-Hinton broth (Difco) were swabbed in three directions with 0.5 McFarland inocula and 6 mm discs containing 5 or 200 mg mupirocin (Oxoid) were applied. Following incubation at 35 uC for 18 h, the diameters of the inhibition zones were determined in mm. The results of mupirocin susceptibility testing related to the 5 mg disc were interpreted as described by Fuchs et al. (1990) . All strains were retested using Mueller-Hinton broth purchased from bioMérieux.
Detection of the mupA gene by PCR. All the strains were analysed by PCR for the presence of the mupA gene, also known as ileS-2, responsible for high-level mupirocin resistance (Nunes et al., 1999) .
Scatterplot. The results were compared by scatterplot analysis. The criteria established by Fuchs et al. (1990) were employed for the 5 mg mupirocin disc.
RESULTS
Criteria to differentiate resistant from susceptible mupirocin strains are well established using the disc diffusion method with the 5 mg disc. . No significant differences in the size of the inhibition zones were observed when culture medium from a different company was used.
The disc diffusion results using the 5 and 200 mg mupirocin discs were plotted on a scatterplot (Fig. 1) . As previously shown, the scatterplot revealed that the 5 mg disc distinguished two groups, susceptible and resistant strains, when a zone size breakpoint of ¢14 mm was used. However, the 5 mg disc was unable to differentiate the two mupirocin-resistant subgroups, which are classified according to their MICs (Mup RL 8-256 mg ml
21
, Mup RH ¢512 mg ml
). The scatterplot for the 200 mg disc showed that, using a zone diameter breakpoint of ¢14 mm, the strains could be differentiated as belonging to either Mup RH 
DISCUSSION
The need for antimicrobial susceptibility testing of S. aureus isolates is becoming more urgent. S. aureus is the most frequently isolated pathogen from nosocomial infections and, due to an increased number of infections caused by MRSA strains, chemotherapy has become difficult (Lowy, 2003) . Mupirocin ointment has been used in nasal decolonization to control MRSA outbreaks, but mupirocin resistance has been observed. The ease of use of the disc diffusion susceptibility test makes it adequate for routine use. This methodology employing a 5 mg mupirocin disc has been established to differentiate resistant from susceptible strains (Finlay et al., 1997; Fuchs et al., 1990) . However, the 5 mg mupirocin disc does not differentiate resistant Mup RL and Mup RH strains. In addition, Palepou et al. (1998) stated that the use of either a 5 or a Fuchs et al. (1990) . A proposed breakpoint zone (¢14 mm) was also used for the 200 mg disc. ) that had been well characterized by the agar dilution method and PFGE , PCR (Nunes et al., 1999) and Etest (Mondino et al., 2003) . We validated the criteria by analysing another 79 S. aureus nosocomial strains. Additional studies should be performed on coagulase-negative Staphylococcus strains in order to establish the criteria required to determine mupirocin susceptibility in this group of micro-organisms.
Clearance of S. aureus nasal colonization can reduce the subsequent risk of development of infection by MRSA, in addition to reducing the spread of these micro-organisms. Therefore, the criteria established in this study could help to identify S. aureus strains with low-level mupirocin resistance in a fast and feasible way. It could be used as an important epidemiological tool in hospitals using large amounts of mupirocin, to guide the possible need for more rigid infection-control measures.
